Alfuzosin (10mg) + Dutasteride (0.5mg)
Zyalfa D 10 mg/0.5 mg Tablet is used in the treatment of benign prostatic hyperplasia.
1 Strip of 10 Tablet
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Zyalfa D 10 mg/0.5 mg Tablet is to be taken with food.
This will help to improve the efficacy of this medicine.
Zyalfa D 10 mg/0.5 mg Tablet is a combination of two medicines: Alfuzosin and Dutasteride, which relieves the symptoms of benign prostatic hyperplasia. Alfuzosin is an alpha-blocker. It works by relaxing the muscle around the bladder exit and prostate gland so as to allow easy passage of urine. Dutasteride is a 5-alpha-reductase inhibitor which helps in shrinking the prostate by decreasing the level of the hormone which helps the prostate gland grow.
Related Warnings
Taking alfuzosin with alcohol can lower your blood pressure. This can cause dizziness or feeling like you might pass out, especially when getting up from a sitting or lying position.
Zyalfa D 10 mg/0.5 mg Tablet is highly unsafe to use during pregnancy.
Human and animal studies have shown significant adverse effects on the foetus. Please consult your doctor.
No information is available on the use of Zyalfa D 10 mg/0.5 mg Tablet during lactation. Please consult your doctor.
Zyalfa D 10 mg/0.5 mg Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Zyalfa D 10 mg/0.5 mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Zyalfa D 10 mg/0.5 mg Tablet may not be needed in these patients. Please consult your doctor.
Zyalfa D 10 mg/0.5 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Zyalfa D 10 mg/0.5 mg Tablet may be needed. Please consult your doctor.
Use of Zyalfa D 10 mg/0.5 mg Tablet is not recommended in patients with severe liver disease.
